Synfacts, Table of Contents Synfacts 2023; 19(04): 0409DOI: 10.1055/s-0042-1752652 Innovative Drug Discovery and Development Design and Synthesis of BCL6 BTB Inhibitor OICR12694 Contributor(s): Antonia F. Stepan (Roche) , Ferdinand H. Lutter (Janssen Pharmaceutica) , Danica A. Rankic (Pfizer) Recommend Article Abstract Buy Article Key words Key wordsnon-Hodgkin lymphoma - BCL6 - protein–protein interaction - structure-based drug design Full Text